About: Drug and therapeutics committees as guardians of safe and rational medicines use

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Drug and therapeutics committees as guardians of safe and rational medicines use Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Drug and therapeutics committees as guardians of safe and rational medicines use
Creator	Cremers, Serge Sofat, Reecha Ferner, R
Source	PMC
abstract	covid:5a34bd8d2b843fa9a95f275b5892e1fb76ef75d3#abstract
has issue date	2019-10-18(xsd:dateTime)
bibo:doi	10.1111/bcp.14088
bibo:pmid	31625180
has license	no-cc
sha1sum (hex)	5a34bd8d2b843fa9a95f275b5892e1fb76ef75d3
schema:url	https://doi.org/10.1111/bcp.14088
resource representing a document's title	Drug and therapeutics committees as guardians of safe and rational medicines use
has PubMed Central identifier	PMC6983503
has PubMed identifier	31625180
schema:publication	Br J Clin Pharmacol
resource representing a document's body	covid:5a34bd8d2b843fa9a95f275b5892e1fb76ef75d3#body_text
is schema:about of	named entity 'medicines' named entity 'licensed' named entity 'Formulary' named entity 'indications' named entity 'British National Formulary' named entity 'drugs' named entity 'combining' named entity 'reasons' named entity 'marketing' named entity 'European' named entity 'EFFICACY' named entity 'SIMILAR' named entity 'WAR' named entity 'COST' named entity 'MOULD' named entity 'COLLEGE' named entity 'MARKETING' named entity 'EUROPEAN' named entity 'SOCIETY' named entity 'MEANS' named entity 'THEIR' named entity 'ESSENTIAL' named entity 'NEED' named entity 'AVAILABILITY OF' named entity 'NEW' named entity 'ACT' named entity 'CLIN' named entity 'STYLE' named entity 'CHOICES' named entity 'DIURETICS' named entity 'INDICATION' named entity 'ADDITION' named entity 'MEET' named entity 'ANTAGONISTS' named entity 'DRUG' named entity 'drugs' named entity 'beta-blockers' named entity '2019' named entity 'range' named entity 'cost-effective' named entity 'antagonists' named entity 'addition' named entity 'mould' named entity 'dosage' named entity 'choices' named entity 'compromised' named entity 'alternatives' named entity 'arterial hypertension' named entity 'Physicians' named entity 'rational' named entity 'British National' named entity 'current' named entity 'identical' named entity 'Thus' named entity 'Pharmacopoeia' named entity 'England' named entity 'drug interactions' named entity 'diuretics' named entity 'similar drugs' named entity 'marketing' named entity 'clinical pharmacologists' named entity 'National Institute for Health and Care Excellence' named entity 'off-label' named entity 'NICE' named entity 'rofecoxib' named entity 'marketing' named entity 'Marketing' named entity 'Formulary' named entity 'biosimilars' named entity 'pharmaceutical industry' named entity 'biosimilars' named entity 'practice medicine' named entity 'ethical approval' named entity 'off-label' named entity 'acetazolamide' named entity 'NHS' named entity 'zolmitriptan' named entity 'health care organizations' named entity 'United Kingdom'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software